Vectura Gets $10M Added To $90M Inhaler IP Award

A Delaware federal judge on Thursday granted British pharma company Vectura’s request for $10.5 million in supplemental damages in a case in which a jury found GlaxoSmithKline willfully infringed a patent covering inhalers, though the judge denied Vectura’s bid for an additional $33 million in enhanced damages…

Read this piece in its entirety at Law360.


Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s